Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AtriCure Raises FY2025 Adj EPS Guidance from $(0.39)-$(0.34) to $(0.26)-$(0.23) vs $(0.49) Est; Raises FY2025 Sales Guidance from $527.000M-$533.000M to $532.000M-$534.000M vs $530.651M Est

Author: Benzinga Newsdesk | October 29, 2025 03:02pm
AtriCure (NASDAQ:ATRC) raises FY2025 Adj EPS guidance from $(0.39)-$(0.34) to $(0.26)-$(0.23) vs $(0.49) analyst estimate. Raises FY2025 sales outlook from $527.000 million-$533.000 million to $532.000 million-$534.000 million vs $530.651 million estimate.

Posted In: ATRC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist